A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of UTTR1147A Compared With Placebo and With Vedolizumab in Participants With Moderate to Severe Ulcerative Colitis (UC)
Condition: Ulcerative Colitis Interventions: Drug: UTTR1147A; Drug: UTTR1147A Placebo; Drug: Vedolizumab; Drug: Vedolizumab Placebo Sponsor: Genentech, Inc. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials